Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06140836 |
|---|---|
| Brief Title: | A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) |
| First Submitted : | November 15, 2023 |
| First Submitted that Met QC Criteria : | November 15, 2023 |
| First Posted : | November 20, 2023 |
| Last Update Submitted that Met QC Criteria : | May 20, 2024 |
| Last Update Posted : | May 21, 2024 (Estimate) |